Literature DB >> 27915009

Exploring gastrointestinal variables affecting drug and formulation behavior: Methodologies, challenges and opportunities.

Bart Hens1, Maura Corsetti2, Robin Spiller3, Luca Marciani3, Tim Vanuytsel4, Jan Tack4, Arjang Talattof5, Gordon L Amidon6, Mirko Koziolek7, Werner Weitschies8, Clive G Wilson9, Roelof J Bennink10, Joachim Brouwers11, Patrick Augustijns12.   

Abstract

Various gastrointestinal (GI) factors affect drug and formulation behavior after oral administration, including GI transfer, motility, pH and GI fluid volume and composition. An in-depth understanding of these physiological and anatomical variables is critical for a continued progress in oral drug development. In this review, different methodologies (invasive versus non-invasive) to explore the impact of physiological variables on formulation behavior in the human GI tract are presented, revealing their strengths and limitations. The techniques mentioned allow for an improved understanding of the role of following GI variables: gastric emptying (magnetic resonance imaging (MRI), scintigraphy, acetaminophen absorption technique, ultrasonography, breath test, intraluminal sampling and telemetry), motility (MRI, small intestinal/colonic manometry and telemetry), GI volume changes (MRI and ultrasonography), temperature (telemetry) and intraluminal pH (intraluminal sampling and telemetry).
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Intestinal absorption; Intraluminal profiling; MRI; Manometry; Scintigraphy; Telemetry

Mesh:

Substances:

Year:  2016        PMID: 27915009     DOI: 10.1016/j.ijpharm.2016.11.063

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  12 in total

Review 1.  Will MRI of gastrointestinal function parallel the clinical success of cine cardiac MRI?

Authors:  Caroline Hoad; Christopher Clarke; Luca Marciani; Martin John Graves; Maura Corsetti
Journal:  Br J Radiol       Date:  2018-10-24       Impact factor: 3.039

2.  Characterization of Phase Transformations for Amorphous Solid Dispersions of a Weakly Basic Drug upon Dissolution in Biorelevant Media.

Authors:  Ahmed Elkhabaz; Sreya Sarkar; Garth J Simpson; Lynne S Taylor
Journal:  Pharm Res       Date:  2019-10-30       Impact factor: 4.200

3.  Osteoporosis treatment with risedronate: a population pharmacokinetic model for the description of its absorption and low plasma levels.

Authors:  B Cardozo; E Karatza; V Karalis
Journal:  Osteoporos Int       Date:  2021-05-17       Impact factor: 4.507

4.  Measuring the Impact of Gastrointestinal Variables on the Systemic Outcome of Two Suspensions of Posaconazole by a PBPK Model.

Authors:  Bart Hens; Arjang Talattof; Paulo Paixão; Marival Bermejo; Yasuhiro Tsume; Raimar Löbenberg; Gordon L Amidon
Journal:  AAPS J       Date:  2018-03-29       Impact factor: 4.009

5.  On the Design of Food Effect Studies in Adults for Extrapolating Oral Drug Absorption Data to Infants: an Exploratory Study Highlighting the Importance of Infant Food.

Authors:  Marina Statelova; Konstantinos Goumas; Nikoletta Fotaki; René Holm; Mira Symillides; Christos Reppas; Maria Vertzoni
Journal:  AAPS J       Date:  2019-12-02       Impact factor: 4.009

6.  Experiments and modeling of controlled release behavior of commercial and model polymer-drug formulations using dialysis membrane method.

Authors:  Alok Ranjan; Prateek K Jha
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

7.  Gastric emptying and intestinal appearance of nonabsorbable drugs phenol red and paromomycin in human subjects: A multi-compartment stomach approach.

Authors:  Paulo Paixão; Marival Bermejo; Bart Hens; Yasuhiro Tsume; Joseph Dickens; Kerby Shedden; Niloufar Salehi; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Jeffrey Wysocki; Bo Wen; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Gail Benninghoff; Raimar Löbenberg; Arjang Talattof; Duxin Sun; Gordon L Amidon
Journal:  Eur J Pharm Biopharm       Date:  2018-05-29       Impact factor: 5.571

8.  In Vivo Dissolution and Systemic Absorption of Immediate Release Ibuprofen in Human Gastrointestinal Tract under Fed and Fasted Conditions.

Authors:  Mark J Koenigsknecht; Jason R Baker; Bo Wen; Ann Frances; Huixia Zhang; Alex Yu; Ting Zhao; Yasuhiro Tsume; Manjunath P Pai; Barry E Bleske; Xinyuan Zhang; Robert Lionberger; Allen Lee; Gordon L Amidon; William L Hasler; Duxin Sun
Journal:  Mol Pharm       Date:  2017-10-05       Impact factor: 4.939

9.  Ribociclib Bioavailability Is Not Affected by Gastric pH Changes or Food Intake: In Silico and Clinical Evaluations.

Authors:  Tanay S Samant; Shyeilla Dhuria; Yasong Lu; Marc Laisney; Shu Yang; Arnaud Grandeury; Martin Mueller-Zsigmondy; Kenichi Umehara; Felix Huth; Michelle Miller; Caroline Germa; Mohamed Elmeliegy
Journal:  Clin Pharmacol Ther       Date:  2017-12-08       Impact factor: 6.875

10.  Linking the Gastrointestinal Behavior of Ibuprofen with the Systemic Exposure between and within Humans-Part 1: Fasted State Conditions.

Authors:  Marival Bermejo; Paulo Paixão; Bart Hens; Yasuhiro Tsume; Mark J Koenigsknecht; Jason R Baker; William L Hasler; Robert Lionberger; Jianghong Fan; Joseph Dickens; Kerby Shedden; Bo Wen; Jeffrey Wysocki; Raimar Löbenberg; Allen Lee; Ann Frances; Gregory E Amidon; Alex Yu; Niloufar Salehi; Arjang Talattof; Gail Benninghoff; Duxin Sun; Gislaine Kuminek; Katie L Cavanagh; Naír Rodríguez-Hornedo; Gordon L Amidon
Journal:  Mol Pharm       Date:  2018-11-12       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.